Our results add ANXA10 to the repertoire of tumor suppressor proteins that are inhibited by Cul4A in cancer, and thus, it suggests Cul4A as a potential drug target for the development of novel therapy for lung cancer in the future. The gene discussed is CUL4A; the disease is cancer.